Pieris Pharmaceuticals Inc., of Freising, Germany, said it is set to receive its third milestone payment for the second program in its discovery and development collaboration with Daiichi Sankyo Co. Ltd., of Tokyo, and seventh milestone payment overall under their multi-program agreement, inked in 2011.